Previous 10 | Next 10 |
The law firm of Kirby McInerney LLP is investigating potential claims against R1 RCM Inc. (“RCM” or the “Company”) (NASDAQ: RCM ). The investigation concerns whether RCM and/or certain of its officers have violated the federal securities laws and/or engaged in ...
2023-10-19 08:03:52 ET R1 RCM: Attractively Priced, Capital Produces $0.90/Share In Earnings, Reiterate Buy R1 RCM a new buy at Citi on revenue cycle management outsourcing Seeking Alpha’s Quant Rating on R1 RCM For further details see: Truist lifts R1...
ATLANTA, Oct. 18, 2023 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether R1 RCM Inc. (“RCM” or “the Company”) (NASDAQ: RCM) complied with federal securities laws. On October 16, 2023, Jehoshaphat Research published a report alleging “RCM&...
MURRAY, Utah, Oct. 16, 2023 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended ...
Boston, Massachusetts--(Newsfile Corp. - October 16, 2023) - Block & Leviton is investigating R1 RCM, Inc. (NASDAQ: RCM) for potential securities law violations. Investors who have lost money in their R1 RCM, Inc. investment should contact the firm to learn more about how they might recover...
2023-09-22 11:50:05 ET More on R1 RCM R1 RCM: Attractively Priced, Capital Produces $0.90/Share In Earnings, Reiterate Buy Seeking Alpha's Quant Rating on R1 RCM Historical earnings data for R1 RCM Financial information for R1 RCM For further details ...
2023-08-08 08:21:03 ET Summary Pediatrix Medical Group's Q2 FY'23 numbers fell short of internal expectations. The company's financials, business economics, current sentiment, and valuation pose notable headwinds for future capital growth, in my view. Sentiment is neutral, wit...
2023-08-02 11:56:10 ET R1 RCM Inc. (RCM) Q2 2023 Earnings Conference Call August 2, 2023, 8:00 AM ET Company Participants Atif Rahim - Head, Investor Relations Lee Rivas - Chief Executive Officer Jennifer Williams - Chief Financial Officer Conference Call P...
2023-08-02 07:13:00 ET R1 RCM press release ( NASDAQ: RCM ): Q2 GAAP EPS of $0.00 in-line. Revenue of $560.7M (+43.1% Y/Y) misses by $0.98M . GAAP net income of $0.3 million, compared to net loss of $20.4 million in the same period last year. Adjusted EBITDA of...
MURRAY, Utah, Aug. 02, 2023 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced results for the three months ended June 30, 2023. Seco...
News, Short Squeeze, Breakout and More Instantly...
MURRAY, Utah, July 24, 2024 (GLOBE NEWSWIRE) -- The Special Committee of the R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”) Board of Directors, which comprises independent directors and was formed to evaluate strategic alternatives in response to the Schedule 13D/A ...
MURRAY, Utah, July 15, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended ...
2024-07-09 09:00:05 ET George Hill from Deutsche Bank issued a price target of $16.00 for RCM on 2024-07-09 07:36:00. The adjusted price target was set to $16.00. At the time of the announcement, RCM was trading at $12.66. The overall price target consensus is at $19.00 ...